Investing-News.Com
Information for Investors

AASTROM BIOSCIENC, (ASTM) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

AASTROM BIOSCIENC, (ASTM) Stock Research Free Stock Rating

 
Company Profile
 
Aastrom Biosciences, Inc., a development stage company, engages in the research and development of processes and products for the ex vivo production of human cells for use in cell therapy. Its product development programs utilize adult bone marrow stem and progenitor cells for forming solid tissues, such as bone, vascular tissue, cartilage, and blood and immune system cells. The company’s Prescription Cell Product pipeline focuses on bone marrow cell products, Tissue Repair Cells (TRCs), for the treatment of bone and vascular regeneration. The primary TRC application includes bone grafting, such as large bone fractures, spine fusions or jaw bone reconstruction. The company’s Cell Production Products, AastromReplicell System and DC-I (dendritic cells for fusion and transfection), DCV-I (complex antigen-loaded dendritic cells), and DCV-II (peptide-loaded dendritic cells) cell production kits are sold to academic researchers and companies that are developing dendritic cell-based cancer vaccines. The AastromReplicell System consists of an instrumentation platform to be integrated within the hospital or other centralized facilities, which can operate various single-use cell production kits that are specific to the desired medical application. Aastrom has strategic alliance with the Musculoskeletal Transplant Foundation to develop and commercialize treatments for the regeneration of tissues, such as bone and cartilage. The company was incorporated in 1989 and is headquartered in Ann Arbor, Michigan.

AASTROM BIOSCIENC Related

Aastrom Biosciences Develops automated cell therapy systems to enable therapeutic procedures using living cells for the restoration of tissues in patients treated for cancer and other diseases.
Aastrom Biosciences, Inc. - 11-07-08: Aastrom Biosciences to Present At Rodman & Renshaw 10th Annual Healthcare Conference ... 11-07-08: Aastrom Biosciences Reports First Quarter Fiscal ...
ASTM AASTROM BIOSCIENCES INC ASTM (AASTROM BIOSCIENCES INC): Stock analyses and research by investors on UpDown.com ... Aastrom Biosciences Receives Notification That NASDAQ Issued Temporary ...
Sponsored Links:

Software Forces AASTROM BIOSCIENC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in AASTROM BIOSCIENC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on AASTROM BIOSCIENC. This software is specially designed to give precision entry and exit points on AASTROM BIOSCIENC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When AASTROM BIOSCIENC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even AASTROM BIOSCIENC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: book on penny stock  day trading stocks  www.timerdigest.com  formula for altman s z score 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Aastrom Announces Treatment of First Patient in U.S. Phase II IMPACT-DCM Trial (GlobeNewswire)

Regenerative Medicine: Big Pharma's Next Frontier (Seeking Alpha)

Regenerative Medicine: Big Pharma's Next Frontier (Seeking Alpha)

AASTROM BIOSCIENCES INC Financials (EDGAR Online Financials)

AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)

AASTROM BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

Aastrom Biosciences Reports First Quarter Fiscal Year 2009 Financial Results (GlobeNewswire)

Aastrom Biosciences to Present At Rodman & Renshaw 10th Annual Healthcare Conference (GlobeNewswire)

How stock sectors could fare in an Obama administration (Reuters)

Genzyme And Osiris "Elect" To Get Together On Stem Cells (at CNBC)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.